IP Library Granted Patent US 11,135,227
Granted Patent B2
US 11,135,227 · App. 16/677,080 · Granted Oct 5, 2021

Oxygen linked pyrimidine derivatives

Inventors: Stephanie Blanchard (Singapore, SG); Cheng Hsia Angelina Lee (Singapore, SG); Harish Kumar Mysore Nagaraj (Singapore, SG); Anders Poulsen (Singapore, SG); Eric T. Sun (Singapore, SG); Yee Ling Evelyn Tan (Singapore, SG); Anthony Deodaunia William (Singapore, SG)
Assignee: CTI BIOPHARMA CORP.
A61K31/5377A61K31/519C07D498/06C07D498/08C07D498/16C07D498/18C07D515/16C07D515/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,135,227
App. No.
16/677,080
Granted
Oct 5, 2021
Kind
B2
Abstract

The present invention relates to pyrimidine compounds that are useful as anti-proliferative agents. More particularly, the present invention relates to oxygen linked and substituted pyrimidine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative disorders including tumours and cancers as well as other disorders or conditions related to or associated with kinases.

Claims (60)

1. A method of synthesis of a compound of formula I

wherein:

R 1 and R 2 are each independently selected from the group consisting of H, halogen, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, heteroalkyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, arylalkyl, heteroarylalkyl, arylalkenyl, cycloalkylheteroalkyl, heterocycloalkylheteroalkyl, heteroarylheteroalkyl, arylheteroalkyl, hydroxy, hydroxyalkyl, alkoxy, alkoxyalkyl, alkoxyaryl, alkenyloxy, alkynyloxy, cycloalkylkoxy, heterocycloalkyloxy, aryloxy, arylalkyloxy, phenoxy, benzyloxy, heteroaryloxy, amino, alkylamino, aminoalkyl, acylamino, arylamino, sulfonylamino, sulfinylamino, —COOH, —COR 3 , —COOR 3 , —CONHR 3 , —NHCOR 3 , —NHCOOR 3 , —NHCONHR 3 , alkoxycarbonyl, alkylaminocarbonyl, sulfonyl, alkylsulfonyl, alkylsulfinyl, arylsulfonyl, arylsulfinyl, aminosulfonyl, —SR 3 , R 4 S(O)R 6 —, R 4 S(O) 2 R 6 —, R 4 C(O)N(R 5 )R 6 —, R 4 SO 2 N(R 5 )R 6 —, R 4 N(R 5 )C(O)R 6 —, R 4 N(R 5 )SO 2 R 6 —, R 4 N(R 5 )C(O)N(R 5 )R 6 — and acyl, each of which can be optionally substituted;

each R 3 , R 4 , and R 5 is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, haloalkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, arylalkyl, heteroarylalkyl and acyl, each of which can be optionally substituted;

each R 6 is independently selected from the group consisting of a bond, alkyl, alkenyl, alkynyl, haloalkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, arylalkyl, heteroarylalkyl and acyl, each of which can be optionally substituted;

Z 2 is —N(R 7 )—,

each R 7 is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, haloalkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, arylalkyl, heteroarylalkyl and acyl, each of which can be optionally substituted;

Ar 1 and Ar 2 are both phenylene, each of which can be optionally substituted;

L is a group of formula:

—X 1 —Y—X 2 —

wherein X 1 is attached to Ar 1 and X 2 is attached to Ar 2 , and wherein X 1 , X 2 and Y are selected such that the group L has between 5 and 15 atoms in the normal chain,

X 1 and X 2 are each independently a heteroalkyl group containing one oxygen atom in the normal chain,

Y is a group of formula —CR a ═CR b —,

wherein R a and R b are each independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, haloalkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, arylalkyl, heteroarylalkyl and acyl, each of which can be optionally substituted, or

R a and R b can be joined such that when taken together with the carbon atoms to which they are attached they form a cycloalkenyl or cycloheteroalkenyl group;

the method including the steps of:

(a) providing a compound of the formula

(b) subjecting the compound to ring closing metathesis;

(c) optionally reacting the double bond thus formed to form a cycloalkyl group.

2. A method according to claim 1 , wherein step (b) involves treating the trifluoroacetic acid (TFA) or hydrochloric acid (HCl) salt of the compound with 5-10 mole % of Grubbs 2 nd generation catalyst in dichloromethane at 40° C.

3. A method according to claim 1 , wherein step (c) includes treating the metathesis product with a freshly prepared ethereal solution of diazomethane (CH 2 N 2 ) in dichloromethane/dioxane at 0° C.

4. A method according to claim 1 , wherein Z 2 is —N(H)—.

5. A method according to claim 1 , wherein Ar 1 is selected from the group consisting of:

wherein V 1 , V 2 , V 3 and V 4 are each independently)C(R 10 );

wherein each R 10 is independently selected from the group consisting of H, halogen, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, heteroalkyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, arylalkyl, heteroarylalkyl, arylalkenyl, cycloalkylheteroalkyl, heterocycloalkylheteroalkyl, heteroarylheteroalkyl, arylheteroalkyl, hydroxy, hydroxyalkyl, alkoxy, alkoxyalkyl, alkoxyaryl, alkenyloxy, alkynyloxy, cycloalkylkoxy, heterocycloalkyloxy, aryloxy, arylalkyloxy, phenoxy, benzyloxy, heteroaryloxy, amino, alkylamino, aminoalkyl, acylamino, arylamino, sulfonylamino, sulfinylamino, —COOH, —COR 3 , —COOR 3 , —CONHR 3 , —NHCOR 3 , —NHCOOR 3 , —NHCONHR 3 , alkoxycarbonyl, alkylaminocarbonyl, sulfonyl, alkylsulfonyl, alkylsulfinyl, arylsulfonyl, arylsulfinyl, amino sulfonyl, —SR 3 , R 4 S(O)R 6 —, R 4 S(O) 2 R 6 —, R 4 C(O)N(R 5 )R 6 —, R 4 S N(R 5 )R 6 —, R 4 N(R 5 )C(O)R 6 —, R 4 N(R 5 )SO 2 R 6 —, R 4 N(R 5 )C(O)N(R 5 )R 6 — and acyl, each of which can be optionally substituted.

6. A method according to claim 1 , wherein Ar 1 is:

wherein:

each R 10 is independently selected from the group consisting of: H, halogen, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, heteroalkyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, arylalkyl, heteroarylalkyl, arylalkenyl, cycloalkylheteroalkyl, heterocycloalkylheteroalkyl, heteroarylheteroalkyl, arylheteroalkyl, hydroxy, hydroxyalkyl, alkoxy, alkoxyalkyl, alkoxyaryl, alkenyloxy, alkynyloxy, cycloalkylkoxy, heterocycloalkyloxy, aryloxy, arylalkyloxy, phenoxy, benzyloxy, heteroaryloxy, amino, alkylamino, aminoalkyl, acylamino, arylamino, sulfonylamino, sulfinylamino, —COOH, —COR 3 , —COOR 3 , —CONHR 3 , —NHCOR 3 , —NHCOOR 3 , —NHCONHR 3 , alkoxycarbonyl, alkylaminocarbonyl, sulfonyl, alkylsulfonyl, alkylsulfinyl, arylsulfonyl, arylsulfinyl, aminosulfonyl, —SR 3 , R 4 S(O)R 6 —, R 4 S(O) 2 R 6 —, R 4 C(O)N(R 5 )R 6 —, R 4 SO 2 N(R 5 )R 6 —, R 4 N(R 5 )C(O)R 6 —, R 4 N(R 5 )SO 2 R 6 —, R 4 N(R 5 )C(O)N(R 5 )R 6 — and acyl, each of which can be optionally substituted; and,

k is an integer selected from the group consisting of 0, 1, 2, 3, and 4.

7. A method according to claim 1 , wherein Ar 2 is a group selected from the group consisting of:

wherein each R 11 is independently selected from the group consisting of H, halogen, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, heteroalkyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, heteroaryl, cycloalkylalkyl, heterocycloalkylalkyl, arylalkyl, heteroarylalkyl, arylalkenyl, cycloalkylheteroalkyl, heterocycloalkylheteroalkyl, heteroarylheteroalkyl, arylheteroalkyl, hydroxy, hydroxyalkyl, alkoxy, alkoxyalkyl, alkoxyaryl, alkenyloxy, alkynyloxy, cycloalkylkoxy, heterocycloalkyloxy, aryloxy, arylalkyloxy, phenoxy, benzyloxy, heteroaryloxy, amino, alkylamino, aminoalkyl, acylamino, arylamino, sulfonylamino, sulfinylamino, —COOH, —COR 3 , —COOR 3 , —CONHR 3 , —NHCOR 3 , —NHCOOR 3 , —NHCONHR 3 , alkoxycarbonyl, alkylaminocarbonyl, sulfonyl, alkylsulfonyl, alkylsulfinyl, arylsulfonyl, arylsulfinyl, amino sulfonyl, —SR 3 , R 4 S(O)R 6 —, R 4 S(O) 2 R 6 —, R 4 C(O)N(R 5 )R 6 —, R 4 SO 2 N(R 5 )R 6 —, R 4 N(R 5 )C(O)R 6 —, R 4 N(R 5 )SO 2 R 6 —, R 4 N(R 5 )C(O)N(R 5 )R 6 — and acyl, each of which can be optionally substituted.

8. A method according to claim 1 , wherein the compound is:

wherein o is an integer selected from the group consisting of 0, 1, 2, 3 and 4.

9. A method according to claim 1 , wherein X 1 and X 2 are each independently selected from the group consisting of:

(a) —OC 1-5 alkyl-,

(b) —C 1-5 alkylO—, and

(c) —C 1-5 alkylOC 1-5 alkyl.

10. A method according to claim 1 , wherein X 1 is selected from the group consisting of:

(a) —OCH 2 —

(b) —CH 2 O—,

(c) —OCH 2 CH 2 —,

(d) —CH 2 CH 2 O—,

(e) —CH 2 OCH 2 —, and

(f) —CH 2 CH 2 OCH 2 —.

11. A method according to claim 1 , wherein X 2 is selected from the group consisting of:

(a) —OCH 2 —

(b) —CH 2 O—,

(c) —OCH 2 CH 2 —,

(d) —CH 2 CH 2 O—,

(e) —CH 2 OCH 2 —, and

—CH 2 CH 2 OCH 2 —.

12. A method according to claim 1 , wherein the compound of formula (I) is selected from the group consisting of:

wherein o is an integer selected from the group consisting of 0, 1, 2, 3 and 4.

13. A method according to claim 1 , wherein R 1 and R 2 are independently selected from the group consisting of H and methyl.

14. A method according to claim 12 , wherein each R 10 is independently selected from the group consisting of H, halogen, amino, alkyl, haloalkyl, haloalkenyl, heterocycloalkyl, aryl, cycloalkylalkyl, heterocycloalkylalkyl, arylalkyl, heteroarylalkyl, cycloalkylheteroalkyl, heterocycloalkylheteroalkyl, heteroarylheteroalkyl, arylheteroalkyl, hydroxy, hydroxyalkyl, alkoxy, and alkoxyalkyl, each of which can be optionally substituted.

15. A method according to claim 12 , wherein each R 10 is independently selected from the group consisting of H, hydroxyl, methoxy, fluoro, methyl, ethyl, propyl, butyl, pentyl, hexyl, phenyl, and 2-morpholino-ethoxy, each of which can be optionally substituted.

16. A method according to claim 12 , wherein each R 11 is independently selected from the group consisting of H, alkoxy, heteroalkyl, heterocycloalkyl, heterocycloalkylheteroalkyl, heteroarylheteroalkyl, and arylsulfonyloxy, each of which can be optionally substituted.

17. A method according to claim 12 , wherein each R 11 is independently selected from the group consisting of:

18. A compound according to claim 1 , wherein Y is selected from the group consisting of:

19. A method according to claim 1 , wherein the compound of formula (I) is selected from the group consisting of:

Assignments (4)
MERGER Recorded Oct 3, 2024
From: CTI BIOPHARMA CORP.
To: SOBI, INC.
Reel/Frame 068782/0512 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2022
From: BLANCHARD, STEPHANIE; LEE, CHENG HSIA ANGELINE; NAGARAJ, HARISH KUMAR MYSORE; POULSEN, ANDERS; SUN, ERIC T.; TAN, YEE LING EVELYN; WILLIAM, ANTHONY DEODAUNIA
To: S*BIO PTE LTD.
Reel/Frame 061244/0723 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2022
From: S*BIO PTE LTD.
To: CELL THERAPEUTICS, INC.
Reel/Frame 061244/0838 →
CHANGE OF NAME Recorded Sep 28, 2022
From: CELL THERAPEUTICS, INC.
To: CTI BIOPHARMA CORP.
Reel/Frame 061561/0842 →
Continuity (8)
Continuation 15398851 · Jan 5, 2017
Division 13771546 · Feb 20, 2013
Division 13438989 · Apr 4, 2012
Division 12093867
Provisional Application 60851283 · Oct 13, 2006
Provisional Application 60817339 · Jun 30, 2006
Provisional Application 60736838 · Nov 16, 2005
Related Publication 20200071339A1 · Mar 5, 2020